163 related articles for article (PubMed ID: 26508558)
1. Brain tumors in patients with myotonic dystrophy: a population-based study.
Gadalla SM; Pfeiffer RM; Kristinsson SY; Björkholm M; Landgren O; Greene MH
Eur J Neurol; 2016 Mar; 23(3):542-7. PubMed ID: 26508558
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk among patients with myotonic muscular dystrophy.
Gadalla SM; Lund M; Pfeiffer RM; Gørtz S; Mueller CM; Moxley RT; Kristinsson SY; Björkholm M; Shebl FM; Hilbert JE; Landgren O; Wohlfahrt J; Melbye M; Greene MH
JAMA; 2011 Dec; 306(22):2480-6. PubMed ID: 22166607
[TBL] [Abstract][Full Text] [Related]
3. Increased cancer risks in myotonic dystrophy.
Win AK; Perattur PG; Pulido JS; Pulido CM; Lindor NM
Mayo Clin Proc; 2012 Feb; 87(2):130-5. PubMed ID: 22237010
[TBL] [Abstract][Full Text] [Related]
4. Quantifying cancer absolute risk and cancer mortality in the presence of competing events after a myotonic dystrophy diagnosis.
Gadalla SM; Pfeiffer RM; Kristinsson SY; Björkholm M; Hilbert JE; Moxley RT; Landgren O; Greene MH
PLoS One; 2013; 8(11):e79851. PubMed ID: 24236163
[TBL] [Abstract][Full Text] [Related]
5. Pigmentation phenotype, photosensitivity and skin neoplasms in patients with myotonic dystrophy.
Gadalla SM; Hilbert JE; Martens WB; Givens S; Moxley RT; Greene MH
Eur J Neurol; 2017 May; 24(5):713-718. PubMed ID: 28317292
[TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
7. Cardiac involvement in myotonic dystrophy: a nationwide cohort study.
Lund M; Diaz LJ; Ranthe MF; Petri H; Duno M; Juncker I; Eiberg H; Vissing J; Bundgaard H; Wohlfahrt J; Melbye M
Eur Heart J; 2014 Aug; 35(32):2158-64. PubMed ID: 24742887
[TBL] [Abstract][Full Text] [Related]
8. Correlates of tumor development in patients with myotonic dystrophy.
Das M; Moxley RT; Hilbert JE; Martens WB; Letren L; Greene MH; Gadalla SM
J Neurol; 2012 Oct; 259(10):2161-6. PubMed ID: 22619053
[TBL] [Abstract][Full Text] [Related]
9. Increased incidence rates but no space-time clustering of childhood astrocytoma in Sweden, 1973-1992: a population-based study of pediatric brain tumors.
Hjalmars U; Kulldorff M; Wahlqvist Y; Lannering B
Cancer; 1999 May; 85(9):2077-90. PubMed ID: 10223251
[TBL] [Abstract][Full Text] [Related]
10. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
11. Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink.
Wang Y; Pfeiffer RM; Alsaggaf R; Meeraus W; Gage JC; Anderson LA; Bremer RC; Nikolenko N; Lochmuller H; Greene MH; Gadalla SM
Int J Cancer; 2018 Mar; 142(6):1174-1181. PubMed ID: 29114849
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
13. Incidence of cancer among patients with atopic dermatitis.
Hagströmer L; Ye W; Nyrén O; Emtestam L
Arch Dermatol; 2005 Sep; 141(9):1123-7. PubMed ID: 16172309
[TBL] [Abstract][Full Text] [Related]
14. Benign and malignant tumors in the UK myotonic dystrophy patient registry.
Alsaggaf R; Wang Y; Marini-Bettolo C; Wood L; Nikolenko N; Lochmüller H; Greene MH; Gadalla SM
Muscle Nerve; 2018 Feb; 57(2):316-320. PubMed ID: 28662292
[TBL] [Abstract][Full Text] [Related]
15. Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe.
Bright CJ; Hawkins MM; Winter DL; Alessi D; Allodji RS; Bagnasco F; Bárdi E; Bautz A; Byrne J; Feijen EAM; Fidler MM; Garwicz S; Grabow D; Gudmundsdottir T; Guha J; Haddy N; Jankovic M; Kaatsch P; Kaiser M; Kuehni CE; Linge H; Øfstaas H; Ronckers CM; Skinner R; Teepen JC; Terenziani M; Vu-Bezin G; Wesenberg F; Wiebe T; Sacerdote C; Jakab Z; Haupt R; Lähteenmäki P; Zaletel LZ; Kuonen R; Winther JF; de Vathaire F; Kremer LC; Hjorth L; Reulen RC;
J Natl Cancer Inst; 2018 Jun; 110(6):649-660. PubMed ID: 29165710
[TBL] [Abstract][Full Text] [Related]
16. Cancers in the first-degree relatives of children with brain tumours.
Hemminki K; Li X; Vaittinen P; Dong C
Br J Cancer; 2000 Aug; 83(3):407-11. PubMed ID: 10917560
[TBL] [Abstract][Full Text] [Related]
17. Cancer phenotype in myotonic dystrophy patients: Results from a meta-analysis.
Emparanza JI; López de Munain A; Greene MH; Matheu A; Fernández-Torrón R; Gadalla SM
Muscle Nerve; 2018 Oct; 58(4):517-522. PubMed ID: 30028904
[TBL] [Abstract][Full Text] [Related]
18. Mobile phones, cordless phones and rates of brain tumors in different age groups in the Swedish National Inpatient Register and the Swedish Cancer Register during 1998-2015.
Hardell L; Carlberg M
PLoS One; 2017; 12(10):e0185461. PubMed ID: 28976991
[TBL] [Abstract][Full Text] [Related]
19. Maternal and perinatal risk factors for childhood brain tumors (Sweden).
Linet MS; Gridley G; Cnattingius S; Nicholson HS; Martinsson U; Glimelius B; Adami HO; Zack M
Cancer Causes Control; 1996 Jul; 7(4):437-48. PubMed ID: 8813432
[TBL] [Abstract][Full Text] [Related]
20. Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013.
Walker EV; Davis FG;
Neuro Oncol; 2019 Feb; 21(3):360-369. PubMed ID: 30649461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
